New device sucks blood clots from lungs in acute PE trial
NCT ID NCT06697314
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial is testing a device called AlphaVac that suctions blood clots out of the lung arteries in people with acute pulmonary embolism (PE). The study will enroll 256 adults with a confirmed PE and signs of heart strain. The main goals are to see if the device reduces heart strain within 48 hours and to track safety over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AlphaVac multipurpose mechanical aspiration (MMA) F1885 system (a device that suctions out blood clots)
What this could lead to
If it works, this could offer a less invasive way to quickly remove dangerous blood clots from the lungs, potentially reducing heart strain and the need for clot-busting drugs.
What could go wrong
This is a single-arm study with no comparison group, so results may be less reliable. The device may not work for everyone, and there are risks like bleeding or damage to blood vessels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Poznan University of Medical Sciences
RECRUITINGPoznan, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••